Mesothelioma Trials: Azacitidine in Combination with Temozolomide

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

Columbia University in New York City and the pharmaceutical companies Schering-Plough and Celgene Corporation are currently conducting a clinical trial of Azacitidine in combination with Temozolomide in patients with mesothelioma or soft tissue sarcoma.

The Phase I study will evaluate the combined drug treatment to determine dosing limits and the effects of the two drugs for the treatment of mesothelioma and sarcoma.

At this time, the study is only being conducted at the Columbia University Medical Center in New York City. For further information, contact Lilian Bastista at Columbia.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.

If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.